<?xml version="1.0" encoding="UTF-8"?>
<p id="Par51">Prespecified subgroup analyses include: patients that received at least one cycle of neoadjuvant treatment, patients that underwent a resection, patients that underwent an R0 resection, patients that completed all scheduled treatment, for the subgroups resectable and borderline resectable pancreatic cancer, patients younger vs. older than 65 years, patients with high and low CA 19–9, and patients with performance score 0 vs. 1.</p>
